Research ArticleConference Report
PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3–4, 2011, Rockville, MD
Arifa S. Khan, Anthony Lubiniecki and Kathryn E. King
PDA Journal of Pharmaceutical Science and Technology November 2012, 66 (6) 502-511; DOI: https://doi.org/10.5731/pdajpst.2012.00895
Arifa S. Khan
1Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892;
Anthony Lubiniecki
2Pharmaceutical Development & Manufacturing Sciences, Janssen Research & Development, LLC, Malvern, Pennsylvania 19355; and
Kathryn E. King
3Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 66, Issue 6
November/December 2012
PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3–4, 2011, Rockville, MD
Arifa S. Khan, Anthony Lubiniecki, Kathryn E. King
PDA Journal of Pharmaceutical Science and Technology Nov 2012, 66 (6) 502-511; DOI: 10.5731/pdajpst.2012.00895
Jump to section
Related Articles
- No related articles found.
Cited By...
- A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection
- Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection
- New Technologies and Challenges of Novel Virus Detection
- Role of Risk Assessments in Viral Safety: An FDA Perspective